Form 4: Cyclo Therapeutics Director William Conkling Reports Stock and Option Transactions

Director William Conkling reports acquisition of common stock in lieu of cash compensation and grant of stock options in Cyclo Therapeutics.

Summary

• On June 3, 2024, William Conkling, a director of Cyclo Therapeutics, Inc., acquired 8,594 shares of common stock.
• These shares were received in lieu of cash compensation for the first quarter of 2024, as per the company's non-employee director compensation policy.
• The shares were valued at $1.28 each, based on the closing price on June 3, 2024.
• Conkling also disposed of 24,839 shares of common stock.
• Additionally, Conkling was granted options to purchase 15,562 shares of common stock at an exercise price of $1.28.
• These options vest over a one-year period in equal quarterly installments and expire on June 3, 2034.
• Conkling also disposed of 15,562 derivative securities.
• Following these transactions, Conkling beneficially owns 24,839 shares of common stock and 15,562 stock options.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing primarily reports routine transactions. The acquisition of shares in lieu of cash is mildly positive, while the disposal of shares is mildly negative. Overall, the impact is likely to be minimal.

Positives

• The grant of stock options and shares in lieu of cash compensation aligns director interests with those of shareholders.

Negatives

• The disposal of 24,839 shares of common stock by the director could be interpreted negatively by investors.

Risks

• Director stock sales could create negative market sentiment.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• Shareholders may view the acquisition of shares in lieu of cash compensation as a positive sign of alignment between management and shareholder interests.
• The disposal of shares could be viewed negatively.

Key Dates